Page last updated: 2024-08-25

clarithromycin and nab741

clarithromycin has been researched along with nab741 in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Apajalahti, J; Fox, J; Frimodt-Møller, N; He, H; Li, J; Nation, RL; Poudyal, A; Siikanen, O; Vaara, M; Vaara, T1
Hussain, Z; Li, Y; Li, Z; Liu, S; Liu, Y; She, P; Wu, Y; Xu, L1
Hussain, Z; Li, L; Li, Y; Li, Z; Liu, S; Liu, Y; She, P; Wu, Y; Xu, L; Yang, Y1

Other Studies

3 other study(ies) available for clarithromycin and nab741

ArticleYear
A novel polymyxin derivative that lacks the fatty acid tail and carries only three positive charges has strong synergism with agents excluded by the intact outer membrane.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:8

    Topics: Animals; Anti-Bacterial Agents; Cell Membrane Permeability; Cricetinae; Cricetulus; Drug Synergism; Fibroblasts; Gram-Negative Bacteria; Guinea Pigs; Lung; Male; Microbial Sensitivity Tests; Polymyxin B; Rats; Structure-Activity Relationship

2010
SPR741, Double- or Triple-Combined With Erythromycin and Clarithromycin, Combats Drug-Resistant
    Frontiers in cellular and infection microbiology, 2022, Volume: 12

    Topics: Animals; Antimicrobial Cationic Peptides; Biofilms; Clarithromycin; Drug Resistance, Multiple, Bacterial; Erythromycin; Klebsiella pneumoniae; Mice; Microbial Sensitivity Tests

2022
Triple combination of SPR741, clarithromycin, and erythromycin against Acinetobacter baumannii and its tolerant phenotype.
    Journal of applied microbiology, 2023, Jan-23, Volume: 134, Issue:1

    Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Biofilms; Clarithromycin; Drug Resistance, Multiple, Bacterial; Erythromycin; Microbial Sensitivity Tests

2023